PYC Therapeutics Limited (AU:PYC) has released an update.
PYC Therapeutics Limited, a clinical-stage biotech firm, is set to conduct an investor webinar on 9 May 2024 to discuss its progress in developing RNA therapies for genetic diseases. The company, pioneering in drug candidates for rare blinding eye diseases, has also signaled upcoming human trials for new treatments targeting eye and kidney diseases slated for mid-2024 and early 2025. Interested shareholders can attend the webinar in person or register online to join the event.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.
